Abstract
Rapid growth of the COVID-19 epidemic in China induced extensive efforts of contact tracing and social-distancing/lockdowns, which quickly contained the outbreak and has been replicated to varying degrees around the world. We construct a novel infectious disease model incorporating these distinct quarantine measures (contact tracing and self-quarantine) as reactionary interventions dependent on current infection levels. Derivation of the final outbreak size leads to a simple inverse proportionality relationship with self-quarantine rate, revealing a fundamental principle of exponentially increasing cumulative cases when delaying mass quarantine or lockdown measures beyond a critical time period. In contrast, contact tracing results in a proportional reduction in reproduction number, flattening the epidemic curve but only having sizable impact on final size when a large proportion of contacts are “perfectly” traced. We fit the mathematical model to data from China on reported cases and quarantined contacts, finding that lockdowns had an overwhelming influence on outbreak size and duration, whereas contact tracing played a role in reducing peak number of infected. Sensitivity analysis and simulations under different re-opening scenarios illustrate the differential effects that responsive contact tracing and lockdowns can have on current and second wave outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
CJB, HG, and JCM are supported by a U.S. National Science Foundation RAPID grant (DMS-2028728). HG was also supported by a grant from the Simons Foundation/SFARI($638193$). CJB is partially supported by an NSF grant (DMS-1815095).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data publicly available or upon request.
